Most patients had a tumor histological type of lung adenocarcinoma, an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 1, and were mostly treated with anti-PD-1 monotherapy. This evidence concerns the gene PDCD1 and neoplasm.